$69 Million

Quotient Limited

Follow-on Offering

Bookrunner, December 2018

Quotient Limited
Quotient Limited is a commercial-stage company, headquartered in Switzerland, focused on transforming blood transfusion diagnostics in global donor and patient testing markets via its innovative MosaiQ instrument platform. Quotient's legacy reagent portfolio markets approved reagent products (72 CE Marked and 63 FDA licensed/cleared) to blood donor testing labs, hospitals, and independent testing labs and is used to identify blood types, detect / identify antibodies in blood plasma, and for quality control